Enfumafungin Derivative MK-3118 Shows IncreasedIn VitroPotency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates

Cristina Jiménez-Ortigosa, Padmaja Paderu, Mary R. Motyl, David S. Perlin
  • Antimicrobial Agents and Chemotherapy, December 2013, ASM Journals
  • DOI: 10.1128/aac.02145-13

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr David S Perlin

In partnership with: